Although PD-L1 expression, tumor mutation burden (TMB), IFNγ-related T-cell-inflated gene expression profile (8) and tumor immune dysfunction and exclusion (TIDE) (9) have been established, these biomarkers and transcriptomic signatures have only low predictive power in independent validation (10). Here, IFNG is linked to neoplasm.